TLR4 and esophageal squamous cell carcinoma: Furthermore, the rhBGN-induced proliferation and migration of ESCC cells were abolished by treatment with a neutralizing antibody against TLR4, as shown by MTS and Transwell migration assays (Figure 4C,D).